Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1275 of 2051 entries
View as:

Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)

Phase: N/A Priority: Normal
NCT ID: NCT01527370 Org: User:
Start: 10/31/12 End: 04/09/13 Due: 04/09/14

A Study of Enlicitide Chloride (MK-0616) in Healthy Participants and Participants Taking Statins (MK-0616-012)

Phase: N/A Priority: Normal
NCT ID: NCT06655311 Org: User:
Start: 09/30/22 End: 01/02/24 Due: 01/02/25

An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)

Phase: N/A Priority: Normal
NCT ID: NCT00092170 Org: User:
Start: 03/31/02 End: 01/31/04 Due: 01/31/05

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)

Phase: N/A Priority: Normal
NCT ID: NCT01189890 Org: User:
Start: 08/16/10 End: 10/31/12 Due: 10/31/13

MK0354 Clinical Efficacy and Tolerability Study (0354-004)

Phase: N/A Priority: Normal
NCT ID: NCT00337415 Org: User:
Start: 05/31/06 End: 08/31/06 Due: 08/31/07

A Study of ProQuad™ in Healthy Children in Korea (V221-023)

Phase: N/A Priority: Normal
NCT ID: NCT00839917 Org: User:
Start: 02/29/08 End: 05/31/08 Due: 05/31/09

Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003)

Phase: N/A Priority: Normal
NCT ID: NCT01353898 Org: User:
Start: 06/21/11 End: 01/03/12 Due: 01/03/13

Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006)

Phase: N/A Priority: Normal
NCT ID: NCT04370873 Org: User:
Start: 06/05/20 End: 01/12/22 Due: 01/12/23

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Phase: N/A Priority: Normal
NCT ID: NCT04924075 Org: User:
Start: 08/12/21 End: 06/04/29 Due: 06/04/30

Lipid Efficacy Study (0524B-022)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00269217 Org: User:
Start: 01/31/06 End: 01/31/07 Due: 01/31/08

V710 First-In-Man (FIM) Study (V710-001)

Phase: N/A Priority: Normal
NCT ID: NCT00303069 Org: User:
Start: 11/30/05 End: 07/31/06 Due: 07/31/07

A Study of MK-8189 in Participants With Bipolar I Disorder (MK-8189-020)

Phase: N/A Priority: Normal
NCT ID: NCT06273774 Org: User:
Start: 04/08/24 End: 08/21/24 Due: 08/21/25

Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033/KEYNOTE-033)

Phase: N/A Priority: Normal
NCT ID: NCT02864394 Org: User:
Start: 09/07/16 End: 10/14/22 Due: 10/14/23

Fifty Two Week Extension Trial of Org 50081 (Esmirtazapine) in the Treatment of Insomnia (P05708)

Phase: N/A Priority: Normal
NCT ID: NCT00610675 Org: User:
Start: 12/07/06 End: 08/17/09 Due: 08/17/10

Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)

Phase: N/A Priority: Normal
NCT ID: NCT02036515 Org: User:
Start: 03/12/14 End: 06/06/16 Due: 06/06/17

MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00533208 Org: User:
Start: 07/31/03 End: 10/31/03 Due: 10/31/04

Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)

Phase: N/A Priority: Normal
NCT ID: NCT01803607 Org: User:
Start: 03/14/13 End: 11/11/14 Due: 11/11/15

A Clinical Study of Enlicitide Decanoate in People With Liver Function Problems (MK-0616-030)

Phase: N/A Priority: Normal
NCT ID: NCT06575959 Org: User:
Start: 09/20/24 End: 05/08/25 Due: 05/08/26

A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)

Phase: N/A Priority: Normal
NCT ID: NCT00551213 Org: User:
Start: 11/21/07 End: 06/04/09 Due: 06/04/10

A Study to Assess the Efficacy of Raltegravir (Isentress®), Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145) (Wirksamkeit Von Isentress® Unter Praxisbedingungen)

Phase: N/A Priority: Normal
NCT ID: NCT01213316 Org: User:
Start: 10/31/10 End: 04/30/15 Due: 04/30/16

Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)

Phase: N/A Priority: Normal
NCT ID: NCT03783078 Org: User:
Start: 02/25/19 End: 02/15/24 Due: 02/15/25

Effect of Ridaforolimus on the Pharmacokinetics of Midazolam (Study MK-8669-044)

Phase: N/A Priority: Normal
NCT ID: NCT01071304 Org: User:
Start: 03/31/10 End: 02/29/12 Due: 02/28/13

A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)

Phase: N/A Priority: Normal
NCT ID: NCT04944992 Org: User:
Start: 08/04/21 End: 10/19/22 Due: 10/19/23

A Study of Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038)

Phase: N/A Priority: Normal
NCT ID: NCT01710501 Org: User:
Start: 12/07/12 End: 01/29/14 Due: 01/29/15

A Study to Compare Forms of Nemtabrutinib (MK-1026) in Healthy Adult Participants (MK-1026-007)

Phase: N/A Priority: Normal
NCT ID: NCT06586671 Org: User:
Start: 08/28/23 End: 11/13/23 Due: 11/13/24